Drug shortage: Etomidate Injection (AMIDATE, ETOMIDATE)
FDA lists 18 presentations as Current. Availability: Unavailable (5), Available (13). Reason: Other; Demand increase for the drug. Companies: Hospira, Inc., a Pfizer Company, Hikma Pharmaceuticals USA, Inc., Eugia US LLC, Mylan Institutional, a Viatris Company, Caplin Steriles, Ltd.….
- Published by source
- 2022-10-05
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-27
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Etomidate Injection AMIDATE ETOMIDATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
- Novaplus label
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2022-10-05
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #872 | new | 2026-10-22 | 67fa21b6fe63…4437f0 | 2a95c4f50396…5a29d8 |
| #1123 | update | 2026-10-23 | 57df9de45bba…5b83e2 | 73d8d4c2b04c…99f22e |
| #1373 | update | 2026-10-23 | bc6e3c9b9453…bf559d | 9cd9fe2e8f52…289502 |
| #2233 | update | 2026-10-27 | 8ebbf997873e…7302c8 | 72105cd6c375…20a1ff |
Chain head: #2286 e212558e872c…954bc1